BIIB = 311 US dollar
+1.72 USD (+0.55%)
change of stock price since yesterday
Stock quotation of Biogen Inc. in US dollar at the last deal. Stock quotations in different stock exchange markets. This is a reference of stock quotations. 1 stock of Biogen Inc. now equals 311 US dollar. 1 stock of Biogen Inc. has become more expensive by 1.72 US dollar. Biogen Inc. stock quote rises since yesterday. |
||||||||||||||||||||
|
||||||||||||||||||||
Biogen Inc. share price in US dollarA month ago, Biogen Inc. stock can be exchanged for 0 US dollar. Six months ago, Biogen Inc. stock could be sold for 0 US dollar. Three years ago, Biogen Inc. stock can be exchanged for 269.46 US dollar. Here is shown a chart of the stock price for different times. 0% per month - the change in the stock price of Biogen Inc.. -0.04% - change in the stock price of Biogen Inc. in US dollar per year. |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
Stock quotes Biogen Inc. US dollar
Today 3 110 USD = 10 stocks of BIIB. Today, 25 stocks of Biogen Inc. can be bought for 7 775 US dollar. Today 50 stocks of BIIB = 15 550 USD. If you have 100 stocks of Biogen Inc., then in the British Virgin Islands you can sell them for 31 100 US dollar. Stock quote converter today for 250 stocks of Biogen Inc. gives 77 750 US dollar. Stock quote converter today gives 155 500 US dollar for 500 stocks of Biogen Inc.. |
BIIB stock price history
Today 500 stocks of BIIB = 311 USD. 2 May 2023, 1 stock of Biogen Inc. costs 309.28 US dollar. 1 May 2023, 1 stock of Biogen Inc. = 311.11 US dollar. The maximum stock price of Biogen Inc. in US dollar in was on 01/05/2023. Biogen Inc. stock price in US dollar on 27 April 2023 - 293.72 US dollar. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biogen Inc.Today's stock price of Biogen Inc. is 311 $. BIIB stock price changed by +0.55% or +1.72 USD since last trading day. You can buy 100 BIIB stocks for 31 100 US dollar or sell 50 BIIB stocks for 15 550 US dollar. Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|